AR118760A2 - Coaglomerados de manitol y de almidón granular comprimibles y de libre fluidez - Google Patents

Coaglomerados de manitol y de almidón granular comprimibles y de libre fluidez

Info

Publication number
AR118760A2
AR118760A2 ARP200101143A ARP200101143A AR118760A2 AR 118760 A2 AR118760 A2 AR 118760A2 AR P200101143 A ARP200101143 A AR P200101143A AR P200101143 A ARP200101143 A AR P200101143A AR 118760 A2 AR118760 A2 AR 118760A2
Authority
AR
Argentina
Prior art keywords
mannitol
comprimible
coaglomerates
granular starch
free fluidity
Prior art date
Application number
ARP200101143A
Other languages
English (en)
Inventor
Damien Passe
Philippe Lefevre
Alain Francois
Baptiste Boit
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of AR118760A2 publication Critical patent/AR118760A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

La presente tiene por objeto coaglomerados de manitol cristalino y de almidón granular, caracterizado porque presentan una comprimibilidad, determinada según un ensayo A, superior a 120 N, de preferencia comprendida entre los 200 y 450 N, y una nota de fluidez, determinada según un ensayo B, comprendida entre 3 y 15 segundos, de preferencia comprendida entre 4 y 8 segundos.
ARP200101143A 2009-04-30 2020-04-23 Coaglomerados de manitol y de almidón granular comprimibles y de libre fluidez AR118760A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0952894A FR2944971B1 (fr) 2009-04-30 2009-04-30 Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre

Publications (1)

Publication Number Publication Date
AR118760A2 true AR118760A2 (es) 2021-10-27

Family

ID=41402540

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP100101479A AR076519A1 (es) 2009-04-30 2010-04-30 Coaglomerados de manitol y de almidon granular comprimibles y de libre fluidez. procedimiento de preparacion.
ARP200101143A AR118760A2 (es) 2009-04-30 2020-04-23 Coaglomerados de manitol y de almidón granular comprimibles y de libre fluidez

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP100101479A AR076519A1 (es) 2009-04-30 2010-04-30 Coaglomerados de manitol y de almidon granular comprimibles y de libre fluidez. procedimiento de preparacion.

Country Status (13)

Country Link
US (4) US9937131B2 (es)
EP (1) EP2424508B1 (es)
JP (1) JP5676566B2 (es)
KR (2) KR101867621B1 (es)
CN (1) CN102413819B (es)
AR (2) AR076519A1 (es)
BR (1) BRPI1014371B1 (es)
CA (1) CA2755992C (es)
ES (1) ES2795824T3 (es)
FR (1) FR2944971B1 (es)
MX (1) MX358382B (es)
RU (1) RU2540914C2 (es)
WO (1) WO2010125313A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
CN104770694B (zh) * 2015-04-15 2020-09-15 中国农业科学院农产品加工研究所 利用马铃薯冲调粉造粒设备进行造粒的方法
FR3038836B1 (fr) * 2015-07-17 2017-07-14 Roquette Freres Granules de mannitol pour compression directe
CA2916077C (en) * 2015-12-22 2023-06-20 Euro-Pharm International Canada Inc. Nicotine-containing solid oral formulations and uses thereof
JP2017158534A (ja) * 2016-03-07 2017-09-14 焼津水産化学工業株式会社 チップ状食品の製造方法及びチップ状食品
KR102151268B1 (ko) 2018-08-24 2020-09-02 주식회사 산하이앤씨 지하수정호 결합 복합 지열시스템 및 그 성능 평가방법
KR102191122B1 (ko) 2019-01-18 2020-12-16 엘지전자 주식회사 전동식 압축기
IT201900002857A1 (it) * 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere
WO2024088560A1 (en) 2022-10-28 2024-05-02 Roquette Freres Compound for formulating moisture sensitive active ingredients
CN116509807B (zh) * 2023-07-04 2023-09-19 山东天力药业有限公司 一种甘露醇颗粒的制备方法
CN117860688B (zh) * 2024-03-12 2024-05-31 山东天力药业有限公司 一种直压级甘露醇颗粒及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
JPS6185331A (ja) * 1984-10-04 1986-04-30 Fuji Kagaku Kogyo Kk 直打用賦形薬の製造法
FR2640876B1 (es) * 1988-12-28 1993-09-24 Jouveinal Sa
DE3903217A1 (de) * 1989-02-03 1990-08-09 Boehringer Ingelheim Vetmed Verfahren zur herstellung fester pharmazeutischer zubereitungen
JPH0977669A (ja) * 1995-09-19 1997-03-25 Takeda Chem Ind Ltd ビタミンｂ群顆粒品の組成物およびその製造方法
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
JPH10158153A (ja) * 1996-11-25 1998-06-16 Nippon Eranko Kk 医薬用硬質ゼラチンカプセル及びその製造方法
GB9802201D0 (en) * 1998-02-03 1998-04-01 Cerestar Holding Bv Free-flowable directly compressible starch as binder,disintegrant and filler for compresion tablets and hard gelatine capsules
ES2233329T3 (es) * 1999-02-15 2005-06-16 Sumitomo Pharmaceuticals Company, Limited Comprimidos que se desintegran rapidamente en la cavidad bucal.
CA2374760A1 (en) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
US6664389B1 (en) * 1999-10-01 2003-12-16 National Starch And Chemical Investment Holding Coporation Highly resistant granular starch
FR2807034B1 (fr) 2000-03-29 2002-06-14 Roquette Freres Mannitol pulverulent et son procede de fabrication
CA2342121C (fr) 2000-03-29 2010-05-25 Roquette Freres Mannitol pulverulent et son procede de preparation
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
JP2004175795A (ja) * 2002-11-13 2004-06-24 Takeda Chem Ind Ltd 薬物の放出性に優れた医薬組成物
KR100535228B1 (ko) * 2003-03-11 2005-12-08 한국유나이티드제약 주식회사 란소프라졸함유 경질캅셀제의 제조방법
CN101269055B (zh) * 2007-03-21 2011-12-14 北京德众万全药物技术开发有限公司 盐酸氨溴索口腔崩解片及其制备方法
CN101181404A (zh) * 2007-11-28 2008-05-21 南京海陵中药制药工艺技术研究有限公司 一种治疗咽部疾病的***片及制备方法
FR2933299B1 (fr) * 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre

Also Published As

Publication number Publication date
ES2795824T3 (es) 2020-11-24
KR20120016075A (ko) 2012-02-22
KR101867621B1 (ko) 2018-06-15
RU2011148600A (ru) 2013-06-10
BRPI1014371B1 (pt) 2021-07-27
MX358382B (es) 2018-08-15
CA2755992C (fr) 2018-04-03
US9937131B2 (en) 2018-04-10
JP2012525361A (ja) 2012-10-22
US20120053249A1 (en) 2012-03-01
EP2424508A1 (fr) 2012-03-07
MX2011011497A (es) 2011-11-18
FR2944971B1 (fr) 2012-09-07
US20220008343A1 (en) 2022-01-13
CN102413819B (zh) 2015-09-09
JP5676566B2 (ja) 2015-02-25
KR20170012593A (ko) 2017-02-02
FR2944971A1 (fr) 2010-11-05
EP2424508B1 (fr) 2020-03-11
WO2010125313A1 (fr) 2010-11-04
BRPI1014371A2 (pt) 2020-09-24
US20200155460A1 (en) 2020-05-21
US20170281550A1 (en) 2017-10-05
AR076519A1 (es) 2011-06-15
RU2540914C2 (ru) 2015-02-10
CN102413819A (zh) 2012-04-11
CA2755992A1 (fr) 2010-11-04
US11364204B2 (en) 2022-06-21

Similar Documents

Publication Publication Date Title
AR118760A2 (es) Coaglomerados de manitol y de almidón granular comprimibles y de libre fluidez
EA201290199A1 (ru) Способы и композиции для получения сквалена с применением дрожжей
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
NI201000093A (es) Toalla para llevar puesta
CL2012000429A1 (es) Uso de cepas de bifidobacterium longum para la elaboracion de una completa composicion que sirve para reducir los sintomas de alergias.
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
DOP2011000084A (es) Uso de ditiina-tetracarboximidas para combatir hongos fitopatogenos
MX2012001310A (es) Metodos para proporcionar efectos beneficos en la cavidad bucal.
DOP2012000245A (es) Composiciones sólidas
AR068556A1 (es) Anticuerpos inmunorreactivos con 5-enolpiruvilshikimato-3-fosfato sintetasa mutante
CL2012002262A1 (es) Durmiente de ferrocarril formado de un material compuesto que comprende un bloque con forma rectangular de dicho material de compuesto, superficies planas definidas sobre algun extremo del lado inferior del durmiente, una parte central, definida sobre el lado inferior del durmiente entre dichas superficies.
GT201200293A (es) Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs)
NI200800176A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de la depresión
AR072161A1 (es) Composicion con gradiente de grasas
CR20110034A (es) Peptidos de señalizacion de la crkl
CL2009001804A1 (es) Uso de un copolimero de vinilamina-vinilformamida y un portador para preparar una composicion destinada a fortalecer las fibras queratinosas.
BR112014014834A2 (pt) composições para cuidado oral
AR111471A2 (es) Composición de combinación sinérgica
CO6571924A2 (es) Combinaciòn, kit y mètodo para reducir la presión intraocular
GT200900293A (es) Derivados de azetidina y su uso como antagonistas de prostaglandina e2
CR20110010A (es) Formulaciones que tienen una compatibilidad mejorada con sustratos no tejidos
PA8841801A1 (es) Métodos para utilizar composiciones de aminopiridina de liberación sostenida
SV2010003755A (es) Nuevos derivados de (piperazinilo con enlaces puente)-1-alcanona y su utilizacion como inhibidores de p75
SV2010003702A (es) Asociacion de la dronedarona con al menos un diuretico, su aplicacion en terapeutica
CL2008002832A1 (es) Metodo para separar una masa de embriones en suspension